- Report
- November 2023
- 98 Pages
Asia Pacific
From €3039EUR$3,450USD£2,671GBP
- Report
- November 2023
- 99 Pages
Europe
From €3039EUR$3,450USD£2,671GBP
- Report
- February 2023
- 206 Pages
Global
From €3919EUR$4,450USD£3,445GBP
- Report
- October 2025
- 101 Pages
Australia
From €2641EUR$2,999USD£2,322GBP
- Report
- August 2024
- 200 Pages
Global
From €3408EUR$3,869USD£2,995GBP
- Report
- April 2024
- 140 Pages
Global
From €4376EUR$4,969USD£3,847GBP
- Report
- October 2022
- 227 Pages
Global
From €3171EUR$3,600USD£2,787GBP
- Report
- October 2025
- 81 Pages
From €3039EUR$3,450USD£2,671GBP
- Report
- September 2020
- 700 Pages
Global
From €4316EUR$4,900USD£3,794GBP
- Report
- November 2025
- 132 Pages
Global
From €837EUR$950USD£735GBP
Organoid technology is a rapidly growing field of biotechnology that focuses on the development of three-dimensional (3D) cell cultures that mimic the structure and function of human organs. Organoids are created from stem cells and are used to study the development and function of human organs in a laboratory setting. They are also used to model diseases and test potential treatments.
Organoids are increasingly being used in drug discovery and development, as well as in personalized medicine. They are also being used to study the effects of environmental toxins on human health.
Organoid technology is a rapidly growing field, with many companies investing in the development of new technologies and products. Companies such as Organovo, Emulate, and TissUse are leading the way in the development of organoid technology. Other companies such as InSphero, Mimetas, and 3D Biomatrix are also developing organoid-based products and services. Show Less Read more
